Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > Antibody levels vary according to vaccine type and previous infection with COVID-19

Antibody levels vary according to vaccine type and previous infection with COVID-19

Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains.
1 Jul 2021
United Kingdom
Research buzz

To read this story

Similar stories

Researchers at the Crick and Dundee University have identified potential antivirals that could be developed into new treatments for COVID-19 or in preparation for future coronaviru… More...

Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fi… More...

Scientists have been receiving help with vital coronavirus research from an unlikely team of data analysts - players of … More...

In case you missed it, catch up with the recording of Jonathan Stoye's Crick Lecture from Thursday 13th April 2021 More...

Researchers at the Crick and the Latvian Institute of Organic Synthesis have designed a compound which blocks a critical… More...

Have your say

 
This website is powered by
ToucanTech